Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398457
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-05-01
Brief Title:
Darzalex Faspro Daratumumab and Hyaluronidase-fihj Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelofibrosis |
| Hematologic Malignancy |
| Bone Marrow Transplant Rejection |
| Acute Myeloid Leukemia AML |
| Myelodysplastic Syndromes MDS |
| Acute Lymphoblastic Leukemia ALL Adult |
| Multiple Myeloma |
| Aplastic Anemia |
| Lymphoma |
| Non Hodgkin Lymphoma |
| Hodgkin Lymphoma |
| Chronic Myeloid Leukemia |